Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Esra
Esra Ogru, Glen Waverley AU
| Patent application number | Description | Published |
|---|---|---|
| 20100209459 | ALKALOID FORMULATIONS - There is provided an alkaloid formulation comprising the reaction product of one or more alkaloids with one or more phosphate derivatives of one or more electron transfer agents. | 08-19-2010 |
| 20110003774 | COMPOUNDS HAVING ANTI-PROLIFERATIVE PROPERTIES - There is provided a method of inhibiting the occurrence of one of more of the following conditions:—the proliferation of monocytes/macrophages; or—the proliferation of smooth muscle cells; or—the expression of CD36 receptors; or—the uptake of oxidized LDL, the method comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents. | 01-06-2011 |
Esra Ogru, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20090004166 | Carrier For Enternal Administration - There is provided a carrier for use in enteral administration of biologically active compounds, said carrier comprising an effective amount of one or more phosphate derivatives of one or more electron transfer agents. | 01-01-2009 |
| 20090005348 | Compounds Having Cytokine Modulating Properties - A method of modulating one or more immuno-regulatory cytokines, such as pro-inflammatory and/or anti-inflammatory cytokines, comprising administering to a subject a therapeutically effective amount of one or more phosphate derivatives of one or more hydroxy chromans, or complexes thereof. | 01-01-2009 |
| 20090036354 | CARRIER COMPRISING ONE OR MORE DI AND/OR MONO-(ELECTRON TRANSFER AGENT) PHOSPHATE DERIVATIVES OR COMPLEXES THEREOF - The invention relates to a carrier for administering biologically active compounds comprising one or more C | 02-05-2009 |
| 20090239827 | COMPOUNDS HAVING LIPID LOWERING PROPERTIES - There is provided a therapy for lowering the blood levels of a lipid selected from the group comprising LDL cholesterol, triglycerides, overall cholesterol and mixtures thereof, the therapy comprising the step of administering an effective amount of one or more phosphate derivatives of one or more electron transfer agents. | 09-24-2009 |
Esra Ozdaryal, Deerfield, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110054414 | Automatic Injection Device - Exemplary embodiments provide a syringe plunger formed of a polymeric material. The syringe plunger includes a pressurizer disposed at a proximal end, and a distal end bifurcated into a first plunger arm having a first conical surface and a second conical surface, and a second plunger arm having a first conical surface and a second conical surface. The distal end includes a first contact surface defined by the first conical surface of the first plunger arm and the first conical surface of the second plunger arm, the first contact surface configured to initially contact a firing engagement mechanism, the first contact surface disposed at a first angle of between about 40° and about 80° relative to a longitudinal axis of the syringe plunger. The distal end also includes a second contact surface defined by the second conical surface of the first plunger arm and the second conical surface of the second plunger arm, the second contact surface configured to contact the firing engagement mechanism subsequent to contact by the first contact surface. | 03-03-2011 |